WALTHAM, Mass.—Fresenius Medical Care North America introduced the Liberty Cycler during the 28th Annual Dialysis Conference in Orlando earlier this month.
The device is designed for use in automated peritoneal dialysis (APD) therapy, which, Fresenius said, is the most frequently used home therapy for the treatment of end-stage renal disease.
Fresenius said the new cycler combines advanced pumping technology with ease of use. The dialysis company said patients and medical personnel throughout initial trials and testing reported enhanced training speeds and confidence with treatment using the device.
“Based on our initial feedback from leading nephrologists,” said Rice Powell, CEO, Renal Therapies Group and Co-CEO of Fresenius Medical Care North America, “we believe that there will be a strong reception for this innovative, easy-to-use product. Our development team, along with caregivers and patients, has worked diligently to create a device that enhances the ease of treatment set-up as well as the intra-dialytic user interface. We are pleased to have reached this significant milestone and are proud to be able to bring this product to the home therapy community.”
